Products
Data
Feature
Plans
Request Demo
Sign Up for Free
Blog
Valuable Targets
Advanced Tech.
Pharmaceutical Insights
Navigate pharmaceutical trends with our insights on targets, institutional pipelines, clinical advances, and new drugs.
Recent blog posts
Latest Hotspot
8 min read
CD151 Biologics Sequence Review Report 2026: CD151 antigen Similarity and Patent-Risk Signals
6 August 2026
A Biology Modality MCP review of CD151 protein-sequence similarity, pairwise alignment, patent-sequence signals and antibody–antigen evidence.
Read →
Latest Hotspot
8 min read
CD14 Biologics Sequence Review Report 2026: Monocyte differentiation antigen CD14 Similarity and Patent-Risk Signals
6 August 2026
A Biology Modality MCP review of CD14 protein-sequence similarity, pairwise alignment, patent-sequence signals and antibody–antigen evidence.
Read →
Latest Hotspot
8 min read
CCL28 Biologics Sequence Review Report 2026: C-C motif chemokine 28 Similarity and Patent-Risk Signals
6 August 2026
A Biology Modality MCP review of CCL28 protein-sequence similarity, pairwise alignment, patent-sequence signals and antibody–antigen evidence.
Read →
Latest Hotspot
8 min read
CCL27 Biologics Sequence Review Report 2026: C-C motif chemokine 27 Similarity and Patent-Risk Signals
6 August 2026
A Biology Modality MCP review of CCL27 protein-sequence similarity, pairwise alignment, patent-sequence signals and antibody–antigen evidence.
Read →
Latest Hotspot
8 min read
CCL23 Biologics Sequence Review Report 2026: C-C motif chemokine 23 Similarity and Patent-Risk Signals
6 August 2026
A Biology Modality MCP review of CCL23 protein-sequence similarity, pairwise alignment, patent-sequence signals and antibody–antigen evidence.
Read →
Latest Hotspot
8 min read
CCL15 Biologics Sequence Review Report 2026: C-C motif chemokine 15 Similarity and Patent-Risk Signals
6 August 2026
A Biology Modality MCP review of CCL15 protein-sequence similarity, pairwise alignment, patent-sequence signals and antibody–antigen evidence.
Read →
Latest Hotspot
8 min read
TGFBRAP1 Biologics Sequence Review Report 2026: Transforming growth factor-beta receptor-associated protein 1 Similarity and Patent-Risk Signals
6 August 2026
A Biology Modality MCP review of TGFBRAP1 protein-sequence similarity, pairwise alignment, patent-sequence signals and antibody–antigen evidence.
Read →
Latest Hotspot
8 min read
TGFBR3 Biologics Sequence Review Report 2026: Transforming growth factor beta receptor type 3 Similarity and Patent-Risk Signals
6 August 2026
A Biology Modality MCP review of TGFBR3 protein-sequence similarity, pairwise alignment, patent-sequence signals and antibody–antigen evidence.
Read →
Latest Hotspot
8 min read
NTRK3 Biologics Sequence Review Report 2026: NT-3 growth factor receptor Similarity and Patent-Risk Signals
6 August 2026
A Biology Modality MCP review of NTRK3 protein-sequence similarity, pairwise alignment, patent-sequence signals and antibody–antigen evidence.
Read →
Latest Hotspot
8 min read
NTRK2 Biologics Sequence Review Report 2026: BDNF/NT-3 growth factors receptor Similarity and Patent-Risk Signals
6 August 2026
A Biology Modality MCP review of NTRK2 protein-sequence similarity, pairwise alignment, patent-sequence signals and antibody–antigen evidence.
Read →
Latest Hotspot
8 min read
NTRK1 Biologics Sequence Review Report 2026: High affinity nerve growth factor receptor Similarity and Patent-Risk Signals
6 August 2026
A Biology Modality MCP review of NTRK1 protein-sequence similarity, pairwise alignment, patent-sequence signals and antibody–antigen evidence.
Read →
8 min read
LILRB1 Biologics Sequence Review Report 2026: Leukocyte immunoglobulin-like receptor subfamily B member 1 Similarity and Patent-Risk Signals
6 August 2026
A Biology Modality MCP review of LILRB1 protein-sequence similarity, pairwise alignment, patent-sequence signals and antibody–antigen evidence.
Read →
<
1
<<
259
260
261
262
263
>>
1670
>